Company profile
InCephalo Therapeutics company profile
InCephalo Therapeutics is a preclinical stage biotech company developing local treatments for neurological diseases with a focus on cancers in the brain. The company's C-Lock or Compartment Lock technology retains biologics, that are applied locally behind the blood-brain barrier, in the central nervous system (CNS) and once they leave the CNS, degrade rapidly in the systemic compartment. Thereby it significantly improves local CNS therapy, a challenging task with regards to achieving high local concentration (for efficacy) and low systemic footprint (to reduce potential side effects).
Business identity
- Website
- http://incephalo.com/
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Founded
- 2021-01-01, Year
Headquarters
- Headquarters
- Allschwil, Basel-Landschaft, Switzerland
- Country code
- CH
- Continent
- Europe